Diaceutics, a leading technology and solutions provider to the life science industry, and Cornerstone AI, a leading AI-based data quality and data enhancement platform, announced a strategic partnership to enhance the accuracy, completeness and usability of data from the DXRX laboratory network.
The collaboration integrates Cornerstone AI’s proprietary lab data algorithms with Diaceutics’ real-world data ecosystem, generating LOINC assignments to deliver faster, more accurate, and clinically meaningful insights. Laboratory data, often disjointed and inconsistent, remains a major hurdle in implementing precision medicine initiatives. By combining Cornerstone AI’s advanced data quality and enhancement technology with Diaceutics’ expertise in real-world data, the partnership addresses this challenge head-on improving overall data integrity. These advancements offer pharmaceutical, biotech, and diagnostics companies a stronger foundation for clinical development, faster market access, and better patient outcomes—delivering significant value across the healthcare ecosystem.
“Diaceutics’ commitment to unlocking the potential of real-world data in advancing precision medicine aligns seamlessly with our mission,” said Viraj Narayanan, CEO of Cornerstone AI. “Our laboratory data module will enable Diaceutics’ to more efficiently resolve data inconsistencies and accelerate the development of targeted therapies—bringing vital treatments to patients faster.”
Also Read: Viz.ai & Guardant Health Partner to Enhance Lung Cancer Care
“At Diaceutics, we understand that precision medicine success starts with precision in the data,” said Scott Phillips, VP of Real-World Data at Diaceutics. “Our partnership with Cornerstone AI underscores our ongoing commitment to innovation in data quality, ensuring that the laboratory insights we provide are as accurate, complete, and clinically relevant as required to support the life sciences industry. High-quality data allows our clients to confidently reduce time-to-value, improve patient stratification, and deliver better patient outcomes.”
Diaceutics and Cornerstone AI are at the forefront of real-world data analytics and precision medicine, empowering pharmaceutical and biotech stakeholders to glean more comprehensive insights from laboratory information. By delivering high-fidelity data that can be interpreted with greater confidence, the two organizations aim to advance patient-centric innovation and accelerate the delivery of critical treatments worldwide.
Source: PRWeb
